For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
If you continue without changing your cookie settings, we'll assume you’re happy with this.
The SLAS2021 Digital International Conference and Exhibition welcomes scientists, engineers, academics, graduate students, post-docs and business leaders from academia, government and industry who want to immerse themselves in the latest life sciences discovery and technology research and new products. SLAS encourages all professionals and students interested in accelerating their knowledge — and career — to attend for dynamic scientific sessions, exhilarating keynotes, new product announcements, poster presentations and virtually-enhanced networking and partnering opportunities. This year’s virtual event will highlight more than 80 scientific talks from 10 educational tracks and 45 vendor tutorials.
Visit Abcam at SLAS2021
Exhibit hall dates: January 25-27, 2021
Stop by and discover our new immunoassay platforms including Catchpoint® SimpleStep ELISA® and FirePlex®-HT which offer you fast, easy and cost-effective results.
Abcam's participation at SLAS
Abcam is proud to virtually exhibit and participate at SLAS Digital. Our experts will be on-hand in our virtual booth throughout the show to connect and speak 1:1 with you. Beyond the virtual booth our scientific participation includes:
Age-related immune dysregulation contributes to increased susceptibility to infection and disease in older adults. Spring Discovery has built an assay that combines high-throughput laboratory automation, high-throughput protein expression assays, high-content imaging, and machine learning to identify a suite of phenotypic features capable of discriminating young vs old donor immune cells in-vitro. The core approach of our system involves generating a number of phenotypic features that cluster with either young or old donor cells. In contrast to most high-throughput immunological assays that rely on surface markers and flow cytometry, we use high-content imaging with broad morphological cell staining palettes coupled with machine image recognition to classify features such as cell type, cell-to-cell interactions, cell activation and cell death. By using the FirePlex-HT 10-plex human cytokine panel we are able to couple the features derived from our imaging with cytokine expression data. Our analytical models incorporate both the features derived from our imaging analysis with the cytokine expression data to determine an age score that serves as a response variable for screening potential age-related therapies. By altering the feature sets included in our model and the weighting for those features we can target our screens to address specific therapeutic aims, such as reducing SARS-CoV-2 infection immune dysregulation in older patients. We have used this system to screen thousands of compounds for their ability to make old immune cells respond more like young immune cells to viral infection. Our findings to-date have revealed beneficial effects from promising therapy candidates for a number of age-related conditions including severe coronavirus disease 2019 (COVID-19).
Catchpoint® SimpleStep ELISA® kits
Fluorescent ELISA kits with a simple 90-minute protocol, high sensitivity and improved linearity over an extended dynamic range. Find out more here.